Osteoclasts support the survival of human plasma cells in vitro

International Immunology

Volumn 20, Issue 6, 2008, Pages 775-782

  Geffroy luseau, Alexandrine ^a,b   Jégo, Gaëtan ^a,b   Bataille, Régis ^a,b,c   Campion, Loïc ^c   Pellat deceunynck, Catherine ^a,b  

^a INSTITUT DE BIOLOGIE   (France)

^b UNIVERSITÉ DE NANTES   (France)

^c CENTRE RENÉ GAUDUCHEAU   (France)

Author keywords

Dendritic cells; Osteoclasts; Plasma cells; Survival

Indexed keywords

APRIL PROTEIN; B CELL ACTIVATING FACTOR; CD20 ANTIGEN; CD38 ANTIGEN; CD45 ANTIGEN; HLA DR ANTIGEN; INTERLEUKIN 6; SYNDECAN 1;

ARTICLE; B LYMPHOCYTE; BONE MARROW CELL; CELL DIFFERENTIATION; CELL INTERACTION; CELL SURVIVAL; CONTROLLED STUDY; DENDRITIC CELL; HUMAN; HUMAN CELL; IN VITRO STUDY; LYMPHOCYTE ACTIVATION; LYMPHOCYTE CULTURE; MEMORY CELL; MONOCYTE; OSTEOCLAST; PHENOTYPE; PLASMA CELL; PRIORITY JOURNAL; QUALITATIVE RESEARCH; QUANTITATIVE STUDY;

ANTIGENS, CD; ANTIGENS, CD40; B-LYMPHOCYTES; CELL COMMUNICATION; CELL DIFFERENTIATION; CELL SEPARATION; CELL SURVIVAL; COCULTURE TECHNIQUES; CONTACT INHIBITION; DENDRITIC CELLS; FLOW CYTOMETRY; HUMANS; IMMUNOMAGNETIC SEPARATION; LYMPHOCYTE ACTIVATION; OSTEOCLASTS; PLASMA CELLS;

EID: 44849141723     PISSN: 09538178     EISSN: 14602377     Source Type: Journal    
DOI: 10.1093/intimm/dxn035     Document Type: Article

References (44)

1. Moser, K., Tokoyoda, K., Radbruch, A., MacLennan, I. and Manz, R. A. 2006. Stromal niches, plasma cell differentiation and survival. Curr. Opin. Immunol. 18:265.
2. Radbruch, A., Muehlinghaus, G., Luger, E. O. et al. 2006, Competence and competition: The challenge of becoming a long-lived plasma cell. Nat. Rev. Immunol. 6:741.
3. Shapiro-Shelef, M. and Calame, K. 2005. Regulation of plasma-cell development. Nat. Rev. Immunol. 5:230.
4. De Vos, J., Hose, D., Reme, T. et al. 2006. Microarray-based understanding of normal and malignant plasma cells. Immunol. Rev. 210:86.
5. Arpin, C., Banchereau, J. and Liu, Y. J. 1997. Memory 8 cells are biased towards terminal differentiation: A strategy that may prevent repertoire freezing. J. Exp. Med. 186:931.
6. Roldan, E., Garcia-Pardo, A. and Brieva, J. A. 1992. VLA-4-fibronectin interaction is required for the terminal differentiation of human bone marrow cells capable of spontaneous and high rate immunoglobulin secretion. J. Exp. Med. 175:1739.
7. Kawano, M. M., Mihara, K., Huang, N., Tsujimoto, T. and Kuramoto, A. 1995. Differentiation of early plasma cells on bone marrow stromal cells requires interleukin-6 for escaping from apoptosis. Blood. 85:487.
8. Merville, P., Dechanet, J., Desmouliere, A. et al. 1996. Bcl-2+ tonsillar plasma cells are rescued from apoptosis by bone marrow fibroblasts. J. Exp. Med. 183:227.
9. Minges Wols, H. A., Underhill, G. H., Kansas, G. S. and Witte, P. L. 2002. The role of bone marrow-derived stromal cells in the maintenance of plasma cell longevity. J. Immunol. 169:4213.
10. Minges Wols, H. A., Ippolito, J. A., Yu, Z. et al. 2007. The effects of microenvironment and internal programming of plasma cell survival. Int. Immunol. 19:837.
11. Garcia De Vinuesa, C., Gulbranson-Judge, A., Khan, M. et al. 1999. Dendritic cells associated with plasmablast survival. Eur. J. Immunol. 29:3712.
12. Withers, D. R., Fiorini, C., Fischer, R. T., Ettinger, R., Lipsky, P. E. and Grammer, A. C. 2007. T cell-dependent survival of CD20+ and CD20- plasma cells in human secondary lymphoid tissue. Blood. 109:4856.
13. Hideshima, T. Bergsagel, P. L., Kuehl, W. M. and Anderson, K. C. 2004. Advance's in biology of multiple myeloma: Clinical applications. Blood. 104:607.
14. Bahlis, N. J., King, A. M., Kolonias, D. et al. 2007. CD28-mediated regulation of multiple myeloma cell proliferation and survival. Blood. 109:5002.
15. Yaccoby, S., Wezeman, M. J., Henderson, A. et al. 2004. Cancer and the microenvironment: Myeloma-osteoclast interactions as a model. Cancer Res. 64:2016.
16. Abe, M., Hiura, K., Wilde, J. et al. 2004. Osteoclasts enhance myeloma cell growth and survival via cell-cell contact: A vicious cycle between bone destruction and myeloma expansion. Blood. 104:2484.
17. Giuliani, N., Rizzoli, V. and Roodman, G. D. 2006. Multiple myeloma bone disease: Pathophysiology of osteoblast inhibition. Blood. 108:3992.
18. Toyosaki-Maeda, T., Takano, H., Tomita, T. et al. 2001. Differentiation of monocytes into multinucleated giant bone-resorbing cells: Two-step differentiation induced by nurse-like cells and cytokines. Arthritis Res. 3:306.
19. Dechanet, J., Merville, P., Durand, I., Banchereau, J. and Miossec, P. 1995. The ability of synoviocytes to support terminal differentiation of activated B cells may explain plasma cell accumulation in rheumatoid synovium. J. Clin. Invest. 95:456.
20. Kukreja, A., Hutchinson, A., Dhodapkar, K. et al. 2006. Enhancement of clonogenicity of human multiple myeloma by dendritic cells. J. Exp. Med. 203:1859.
21. Spisek, R., Chevallier, P., Morineau, N. et al. 2002. Induction of leukemia-specific cytotoxic response by cross-presentation of late-apoptotic leukemic blasts by autologous dendritic cells of nonleukemic origin. Cancer Res. 62:2861.
22. Jego, G., Bataille, R. and Pellat-Deceunynck, C. 2001. Interleukin-6 is a growth factor for nonmalignant human plasmablasts. Blood. 97:1817.
23. Arpin, C., Dechanet, J., Van Kooten, C. et al. 1995. Generation of memory B cells and plasma cells in vitro. Science. 268:720.
24. Jego, G., Robillard, N., Puthier, D. et al. 1999. Reactive plasmacytoses are expansions of plasmablasts retaining the capacity to differentiate into plasma cells. Blood. 94:701.
25. Avery, D. T., Kalled, S. L., Ellyard, J. I. et al. 2003. BAFF selectively enhances the survival of plasmablasts generated from human memory B cells. J. Clin. Invest. 112:286.
26. Medina, F., Segundo, C., Campos-Caro, A., Gonzalez-Garcia, I. and Brieva, J. A. 2002. The heterogeneity showz by human plasma cells from tonsil, blood, and bone marrow reveals graded stages of increasing maturity, but local profiles of adhesion molecule expression. Blood 99:2154.
27. Robillard, N., Pellat-Deceunynck, C. and Bataille, R. 2005. Phenotypic characterization of the human myeloma cell growth fraction. Blood. 105:4845.
28. Moreaux, J., Cremer, F. W., Reme, T. et al. 2005. The level of TACI gene expression in myeloma cells is associated with a signature of microenvironment dependence versus a plasmablastic signature. Blood 106:1021.
29. O'Connor, B. P., Raman, V. S., Erickson, L. D. et al. 2004. BCMA is essential for the survival of long-lived bone marrow plasma cells. J. Exp. Med. 199:91.
30. Ingold K., Zumsteg, A., Tardivel, A. et al. 2005. Identification of proteoglycans as the APRIL-specific binding partners. J. Exp. Med. 201:1375.
31. Moreaux, J., Legouffe, E., Jourdan, E. et al. 2004. BAFF and APRIL protect myeloma cells from apoptogis induced by interleukin 6 deprivation and dexamethasone. Blood. 103:3148.
32. Jelinek, D. F. and Lipsky, P. E. 1983. The role of B cell proliferation in the generation of immunoglobulin-secreting cells in man. J. Immunol. 130:2597.
33. Tangye, S. G., Avery, D. T. and Hodgkin, P. D. 2003. A division-linked mechanism for the rapid generation of Ig-secreting cells from human memory B cells. J. Immunol. 170:261.
34. Chen-Kiang, S. 2003. Cell-cycle control of plasma cell differention and tumorigenesis. Ummunol. Rev. 194;39.
35. Hebel, K., Griewank, K., Inamine, A. et al. 2006. Plasma cell differentiation in T-independent type 2 immune responses is independent of CD11c(high) dendritic cells. Eur. J. Immunol. CXCL12. IL-6 and CD54. Eur. J. Immunol. 35:699.
36. Ellyan, J. I., Avery, T., Mackay, C. R. and Tangye, S. G. 2005. Contriution of stromal cells to the migration, function and retention of plasma-cells in human spleen: Potential roles of CXCL-12. IL-6 and-CD54, Eur J. Immunol. 35:699.
37. Zhang, X., Park, C. S., Yoon, S. O. et al. 2005. BAFF supports human B cell differentiation in the lymphoid follicles through distinct receptors. Int. Immunol. 17:779.
38. Rossi, J. F., Moreaux, J., Rose, M. et al. 2006. A phase I/II study of atacicept (TACI-Ig) to neutralize APRIL and BlyS in patients with efractory or relapsed multiple myeloma or active previously treated Waldenstrom's macroglobulinemia. Blood. 108:3578(ASH annual meeting abstracts).
39. Odendahl, M., Mei, H., Hoyer, B. F. et al. 2005. Generation of migratory antigen-specific plasma blasts and mobilization of resident plasma cells in a secondary immune response. Blood. 105:1614.
40. Gonzalez-Garcia, I., Ocana, E., Jimenez-Gomez, G., Campos-Caro, A. and Brieva, J. A. 2006. Immunization-induced perturbation of human blood plasma cell pool: Progressive maturation, IL-6 responsiveness, and high PRDI-BF1/BLIMP1 expression are critical distinctions between antigen-specific and nonspecific plasma cells. J. Immunol. 176:4042.
41. Rivollier, A., Mazzorana, M., Tebib, J. et al. 2004. Immature dendritic cell transdifferentiation into osteoclasts: A novel pathway sustained by the rheumatoid arthritis microenvironment. Blood. 104:4029.
42. Cassese, G., Arce, S., Hauser, A. E. et al. 2003. Plasma cell survival is mediated by synergistic effects of cytokines and adhesion-dependent signals. J. Immunol. 171:1684.
43. Tokoyoda, K., Egawa, T,. Sugiyama, T., Choi, B. I. and Nagasawa, T. 2004. Cellular niches controlling B lymphocyte behavior within bone marrow during development. Immunity 20:707.
44. Menoret, E., Gomez-Bougie, P., Geffroy-Luseau, A. et al. 2006. Mcl-1L cleavage is involved in TRAIL-R1- and TRAIL-R2-mediated apoptosis induced by HGS-ETR1 and HGS-ETR2 human mAbs in myeloma cells. Blood 108:1346.